What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Stock Thread (15 Viewers)

Pretty terrifying interview from Gottlieb today. CYDY didn't get a shout-out but sounds like our hopes rest on a treatment.

https://www.cnbc.com/2020/04/02/former-fda-chief-scott-gottlieb-coronavirus-drug-needed-by-fall.html

“If we don’t have it, this virus is going to come back in the fall and it’s going to continue to shut down parts of our lives,” Gottlieb said on CNBC’s “Squawk Box.” 

“We really need to figure that a vaccine might be two years away,” argued Gottlieb, a CNBC contributor who sits on the boards of Pfizer and biotech company Illumina. 
Took 'em long enough to figure that out. I've said from day one, you will need a treatment or a vaccine or this never ends.

 
yep.  pump and dumb in the afternoon looks like.  
I’ll wait on it. It was over 6 the first chance I got to look. I’m not a pre-market trader. I would have bought in the 4s, but unless you have full time to watch that you never got that in normal trading.

 
It has shown staying power. If momentum and pump and dumpers had a hold of it, it would be back under 2 by now.
Agreed.  I've played and followed enough OTC's throughout the years and witnessed that huge jump, pump & dump many times.  I like what I'm seeing happening with CYDY here.  

 
I got out of 3/4 of my CYDY and wishing I hadn’t...  we shall see.  I’ll leave the rest rolling. 
Always room to jump back in a bit lower and buy some nice steaks with the take-out steak (been reading that online steaks thread and now I'm hungry)

 
Zoom really f'd themselves with this privacy thing. And me for buying in at a high point. Looks like I'm in this one for the long haul to try and head back up.
Sold my ZM this morning, a little scared off by privacy issues.  Got in at a good time so was still up, will take my chances somewhere else.

 
LK down to $6.85.  Luckin is suckin.
What got people following LK?  Never heard of it.  See it had to pause today for volatility.  

Lucken Coffee shares are trading lower after the company announced that a special committee brought to the attention of the board information that the COO fabricated certain transactions.

 
Last edited by a moderator:
CytoDyn says coronavirus patients treated with leronlimab show initial improvements after three days

https://www.proactiveinvestors.com/companies/news/916491/cytodyn-says-coronavirus-patients-treated-with-leronlimab-show-initial-improvements-after-three-days-916491.html

CytoDyn Inc (OTCQB:CYDY) announced Thursday that eight severe coronavirus (COVID-19) patients being treated with its drug leronlimab have shown a significant improvement after three days in several important biologic markers. 

Initial patient test data has shown improvement in cytokines — proteins released by the immune system that can cause inflammation in high quantities  — and a more normal ratio of helper T cells to killer T cells in the immune system, known as the CD4/CD8 ratio.

Leronlimab has been administered to 10 severely ill coronavirus patients in the New York City area under an emergency Investigational New Drug application granted by the US Food & Drug Administration (FDA).

CytoDyn is also enrolling patients in a Phase 2 trial for coronavirus patients with mild-to-moderate indications and a Phase 2b/3 trial for patients who are critically ill.

Bruce Patterson, the CEO of CytoDyn’s diagnostic partner and advisor IncellDX, is impressed with the results so far.

“We are very pleased with our most recent laboratory data for patients treated with leronlimab for COVID-19 infection,” Patterson said in a statement.

“We continue to see increases in the profoundly decreased CD8 T-lymphocyte percentages by day three, normalization of CD4/CD8 ratios and resolving cytokine production including reduced IL-6 correlating with patient improvement. The current data suggests a trend toward the restoration of immune function and mitigation of the cytokine storm. This is consistent with prior laboratory results in the first four patients treated for COVID-19 with leronlimab.”

Seeing leronlimab’s initial success, CEO Nader Pourhassan and his team are also examining how best to distribute the drug across the country.

“As leronlimab continues to provide hope for many patients, our management team is focused to ensure we can distribute the drug across the country in a timely fashion,” Pourhassan said. “These results, although anecdotal, appear to be very promising.”

In addition to its use as a potential coronavirus treatment, leronlimab has other therapeutic indications as a treatment for HIV and certain breast cancers.

 
Probably not a bad buy. They fabricated sales of $300M but it looks like they are running over $3B in sales so around a 10% lie. Probably worth a dabble for me as well DCA my purchase down to say $6-8 a share and hold.

I own around 100 shares so might be worth @$1k to get 300 more and get my DCA to $9 a share.
Isn't the SEC going to string them up? Cannot imagine buying into a company in that kind of situation. Actually considering buying puts if it races back up to 9 bucks again.

 
Thanks @Don Hutson for posting the Proactive story.  Here's the PR from this am.

Highlights from both the PR and paid Proactive "story":

  • 8/10 patients showing significant improvement after 3 days
  • all 10 patients were severely ill; think ventilator 
  • "The current data suggests a trend toward the restoration of immune function and mitigation of the cytokine storm."
  • “As leronlimab continues to provide hope for many patients, our management team is focused to ensure we can distribute the drug across the country in a timely fashion”
 
Isn't the SEC going to string them up? Cannot imagine buying into a company in that kind of situation. Actually considering buying puts if it races back up to 9 bucks again.
They are shielded from the SEC by the Chinese government.  Don't have to file outside of China.  

 
Man, not a great day for me. ZM, LK and SHOP getting dinged. I did buy ZM in the 60s so not going to complain. The only stock in a bunch I looked in October that has held up completely is TDOC and of course I didn’t buy that when it was also in the 60s. SMH sometimes you just miss.
I'm in TDOC for the long haul, but I can't imagine the current price is justified. 

 
Thanks @Don Hutson for posting the Proactive story.  Here's the PR from this am.

Highlights from both the PR and paid Proactive "story":

  • 8/10 patients showing significant improvement after 3 days
  • all 10 patients were severely ill; think ventilator 
  • "The current data suggests a trend toward the restoration of immune function and mitigation of the cytokine storm."
  • “As leronlimab continues to provide hope for many patients, our management team is focused to ensure we can distribute the drug across the country in a timely fashion”
Odd that it's drifting down on the news. Profit taking? 

 
I am looking at adding another chain restaurant. 

TXRH (Texas Roadhouse)

Love the brand, they are a solid growing company and I think will be another survivor in the chain restaurant industry. 

12 month price target for me is $50-52 per share. 24 month $70 per share.

May nibble on this too when we feel we are/on our way to re-testing the lows. 

Market has been quite resilient this week considering how bad it was at the 3/23 low. Taking the bad unemployment numbers in stride. 

Not rushing in....we have a while before we start looking forward to a more normalized life again. 

This suuuuuuuuucks. 

 
Last edited by a moderator:
Isn't the SEC going to string them up? Cannot imagine buying into a company in that kind of situation. Actually considering buying puts if it races back up to 9 bucks again.
I disagree. I think the fake reporting boosted value less than 20% (SWAG), which should out it around 20

 
Thanks @Don Hutson for posting the Proactive story.  Here's the PR from this am.

Highlights from both the PR and paid Proactive "story":

  • 8/10 patients showing significant improvement after 3 days
  • all 10 patients were severely ill; think ventilator 
  • "The current data suggests a trend toward the restoration of immune function and mitigation of the cytokine storm."
  • “As leronlimab continues to provide hope for many patients, our management team is focused to ensure we can distribute the drug across the country in a timely fashion”
Chet- why do they keep paying for stories? Doesn't seem odd to you? Thanks of course for always pointing out that they're paid articles. 

 
Just sold have of my PEATF, leaving me 5000 free shares plus 800 bucks or whatever in profit. Locking in profits and still get to satisfy FOMO.
I have no idea who this handsome, long-donged devil is,  but I believe he sold the rest at .20 netting him almost $2,000 overall, so he'd like to personally THANK @General Malaise for the sweet cobalt tip. 

 
Last edited by a moderator:
I am looking at adding another chain restaurant. 

TXRH (Texas Roadhouse)

Love the brand, they are a solid growing company and I think will be another survivor in the chain restaurant industry. 

12 month price target for me is $50-52 per share. 24 month $70 per share.

May nibble on this too when we feel we are/on our way to re-testing the lows. 

Market has been quite resilient this week considering how bad it was at the 3/23 low. Taking the bad unemployment numbers in stride. 

Not rushing in....we have a while before we start looking forward to a more normalized life again. 

This suuuuuuuuucks. 
I'd love to, but staying away from sitdown restaurants until a bigger leg down. If I get back in, it will def be TXRH, although I'm still hot on JACK, mostly because drive-through is what they do, and should be more impervious to the virus. I sold a bunch around 35 and will dive back in if it goes under 30

 

Users who are viewing this thread

  • Back
    Top